(Q79314186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

G Untergasser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

P L Moser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

M H Zaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

H Steiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

H Rumpold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

D Fuchs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Hobisch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J A Nemeth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Z Culig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

30 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2822-2832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17072336%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-6 in biology and medicine

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Characterization of the role of IL-6 in the progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 is an autocrine growth factor in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Calcium signaling and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Cytokines and signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

The role of IL-6 and STAT3 in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Molecular and cellular biology of interleukin-6 and its receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Role of calcium in the programmed death of rat prostatic glandular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Regulation of cell death: the calcium-apoptosis link

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

The ERK cascade: a prototype of MAPK signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6 and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Raf kinase as a target for anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Interleukin-6: a candidate mediator of human prostate cancer morbidity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021

Myeloid cell factor-1 is a critical survival factor for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210097

7 January 2021